Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients.

摘要: Hematopoietic stem cell transplants (HSCTs) are used to treat a variety of conditions, including hematologic malignancies, bone marrow failure syndromes, and immunodeficiencies. Over 60,000 HSCTs performed annually worldwide, the numbers continue increase. Indeed, as new conditioning regimens develop, more individuals, those older age, will be eligible for transplants. Nevertheless, although clearly life-saving necessary treatment thousands patients per year, there is still substantial morbidity mortality associated with procedure. Of note, skin eruptions in post-HSCT period frequent often significantly reduce quality life recipients. Moreover, these cutaneous findings sometimes herald an underlying systemic condition, presenting possible opportunities timelier intervention. Dermatologists therefore play vital role distinguishing life-threatening conditions from benign issues prompting recognition critical complications earlier their course. This article aims review major dermatologic occurring early period.